Utilities of the EQ-5D Transferable or Not?

被引:88
|
作者
Knies, Saskia [1 ]
Evers, Silvia M. A. A. [1 ]
Candel, Math J. J. M. [2 ]
Severens, Johan L. [1 ,3 ]
Ament, Andre J. H. A. [1 ]
机构
[1] Maastricht Univ, Dept HOPE, Sch Publ Hlth & Primary Care Innovat CAPHRI, NL-6200 MD Maastricht, Netherlands
[2] Maastricht Univ, Dept Methodol & Stat, NL-6200 MD Maastricht, Netherlands
[3] Univ Hosp Maastricht, Dept Clin Epidemiol & MTA KEMTA, Maastricht, Netherlands
关键词
VALUATIONS; US;
D O I
10.2165/11314120-000000000-00000
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background: Within the framework of economic evaluations, the transferability of utility scores between jurisdictions remains unclear. The EQ-5D is a generic instrument for measuring health-related quality of life in economic evaluations, which can be used for comparing utility scores across countries. At present, the EQ-5D has several national value sets or tariffs. Nevertheless, utility estimates from foreign studies are often used directly for cost-effectiveness estimates, without adapting by applying the appropriate national value set. It is unclear if this practice is advisable, due to dissimilarities between the national value sets. Objective: To examine the effects of differences in national EQ-5D value sets on absolute and marginal utilities of health states, and determine to what degree these differences can be explained by methodological factors. Methods: First, the relative importance of the EQ-5D domains for the utility estimates was compared across the 15 value sets. Second, two hypothetical health states for a depressed patient and a pain patient (21232 and 33321) were selected for additional analysis, by comparing the utilities as scored by the value sets. The marginal influence of a one-level deterioration in a domain of these health states on the utility estimate was then determined. Third, the differences between the value sets were examined in more detail by using multilevel analysis to examine the role of methodological differences in the valuation studies. Results: Differences can be perceived between the national value sets of the EQ-5D in the preferences for the domains. The utilities of the two hypothetical health states show that the value sets differ substantially. Furthermore, the differences between the marginal values of the deteriorations are large, which can be explained partly by the type of valuation method. Other methodological differences also influence the value sets. Conclusion: All results indicate that the differences between the EQ-5D value sets are considerable and should not be ignored. The differences can largely be explained by methodological differences in the valuation studies. The remaining differences may reflect cultural dissimilarities between countries. Therefore, further research should focus on investigating the transferability or utilities across Countries or agreeing on a standard to perform valuation studies. For the time being, transferring utilities from one country to another without any adjustment is not advisable.
引用
收藏
页码:767 / 779
页数:13
相关论文
共 50 条
  • [1] UTILITIES OF THE EQ-5D: TRANSFERABLE OR NOT? INFLUENCE OF THE NATIONAL VALUE SETS OF THE EQ-5D ON THE INCREMENTAL UTILITIES OF TWO HEALTH STATES
    Knies, S.
    Evers, S. M. A. A.
    Severens, J. L.
    Candel, M. J. J. M.
    Ament, A. J. H. A.
    VALUE IN HEALTH, 2008, 11 (06) : A575 - A575
  • [2] Health Utilities Using the EQ-5D in Studies of Cancer
    A. Simon Pickard
    Caitlyn T. Wilke
    Hsiang-Wen Lin
    Andrew Lloyd
    PharmacoEconomics, 2007, 25 : 365 - 384
  • [3] EQ-5D Utilities in Chronic Spontaneous/Idiopathic Urticaria
    Emma Hawe
    Doreen McBride
    Maria-Magdalena Balp
    Haijun Tian
    Anna Halliday
    Donald E. Stull
    PharmacoEconomics, 2016, 34 : 521 - 527
  • [4] Health utilities using the EQ-5D in studies of cancer
    Pickard, A. Simon
    Wilke, Caitlyn T.
    Lin, Hsiang-Wen
    Lloyd, Andrew
    PHARMACOECONOMICS, 2007, 25 (05) : 365 - 384
  • [5] EQ-5D Utilities in Chronic Spontaneous/Idiopathic Urticaria
    Hawe, Emma
    McBride, Doreen
    Balp, Maria-Magdalena
    Tian, Haijun
    Halliday, Anna
    Stull, Donald E.
    PHARMACOECONOMICS, 2016, 34 (05) : 521 - 527
  • [6] EQ-5D HEALTH UTILITIES ARE ESTIMATED SUBJECT TO CONSIDERABLE UNCERTAINTY
    Pullenayegum, E. M.
    Xie, F.
    VALUE IN HEALTH, 2014, 17 (03) : A195 - A195
  • [7] MAPPING THE INSOMNIA SEVERITY INDEX (ISI) TO THE EQ-5D UTILITIES
    Gu, N. Y.
    Ji, X.
    Bell, C.
    Botteman, M.
    VALUE IN HEALTH, 2011, 14 (03) : A208 - A208
  • [8] Deriving preference based utilities for IBD patients: Converting IBDQ into EQ-5D utilities
    Casellas, Francesc
    Punekar, Yogesh
    Morris, James
    GASTROINTESTINAL ENDOSCOPY, 2008, 67 (05) : AB318 - AB319
  • [9] How the EQ-5D utilities are derived matters in Chinese diabetes patients: a comparison based on different EQ-5D scoring functions for China
    Chen-Wei Pan
    Ruo-Yu Zhang
    Nan Luo
    Jun-Yi He
    Rui-Jie Liu
    Xiao-Hua Ying
    Pei Wang
    Quality of Life Research, 2020, 29 : 3087 - 3094
  • [10] Comparison of EQ-5D and SF-6D utilities in Pompe disease
    Kanters, T. A.
    Redekop, W. K.
    Kruijshaar, M. E.
    van der Ploeg, A. T.
    Rutten-van Molken, M. P. M. H.
    Hakkaart, L.
    QUALITY OF LIFE RESEARCH, 2015, 24 (04) : 837 - 844